Substituted isoxazole amide compounds as inhibitors of stearoyl-CoA desaturase 1 (SCD1)
申请人:Hoffman-La Roche Inc.
公开号:US09296711B2
公开(公告)日:2016-03-29
The invention is concerned with a compound of formula (I) and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and using the compound of formula (I) as well as pharmaceutical compositions containing such compounds. The compound of formula (I) are SCD1 inhibitors and may be useful in treating cancer.
该发明涉及公式(I)的化合物及其药学上可接受的盐。此外,本发明还涉及制造和使用公式(I)的化合物的方法,以及含有这种化合物的制药组合物。公式(I)的化合物是SCD1抑制剂,可能对治疗癌症有用。